Evolving Alzheimer’s Disease Clinical Practice: Updated Diagnostic Criteria, Fluid Biomarkers, and Special Considerations for Anti-Amyloid Therapies
Biomarker-oriented diagnosis and anti-amyloid therapies are reshaping AD care. Priorities include rigorous validation of BBMs across populations, equitable access to core biomarkers, safety strategies, and real-world evidence to implement maintenance and special-population care pathways.
Authors
- Jae Nam Bae (ORCID: https://orcid.org/0000-0002-5024-6231)
- Keun You Kim (ORCID: https://orcid.org/0000-0001-7192-2828)
- Eosu Kim
- Yoon Young Chang
- Hyun Woong Roh
- So Yeon Jeon
- Sheng-Min Wang
Institutions
- Seoul National University (KR)
- Yonsei University (KR)
- Seoul Metropolitan Government (KR)
- Konkuk University Medical Center (KR)
- The Catholic University of Korea Yeouido St. Mary's Hospital (KR)
- Inje University Sanggye Paik Hospital (KR)
- Inha University Hospital (KR)
- Ajou University (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- Psychiatry Investigation
- Published
- 2026-02-03
- DOI
- https://doi.org/10.30773/pi.2025.0400
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Research Foundation
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea